CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Quality Circle Deprescribing Moduleother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03688542
NCT03688542N/ACompleted

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module

Anne Niquille·interventional·Posted Sep 28, 2018·Updated Apr 21, 2021

In Brief

A clinical study evaluating Quality Circle Deprescribing Module for Polypharmacy and Inappropriate Prescribing. Completed, enrolled 56 participants across 1 site.

Detailed Summary

Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments. The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 28, 2018
Enrollment StartSep 25, 2017
Primary CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7.8 years ago

Interventions

Quality Circle Deprescribing Moduleother

The Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus..